Literature DB >> 22298905

Parent and child acceptable symptom state in juvenile idiopathic arthritis.

Giovanni Filocamo1, Alessandro Consolaro, Benedetta Schiappapietra, Nicolino Ruperto, Angela Pistorio, Nicoletta Solari, Silvia Pederzoli, Sara Verazza, Alberto Martini, Angelo Ravelli.   

Abstract

OBJECTIVE: To explore the parent and child acceptable symptom state in juvenile arthritis (JA-PASS and JA-CASS, respectively) and estimate the JA-PASS and JA-CASS cutoff values for outcome measures.
METHODS: Children with juvenile idiopathic arthritis (JIA) and their parents completed a multi-dimensional questionnaire that included parent-reported and child-reported outcomes and a question about whether they considered the disease state as satisfactory. Additional assessments included demographic data, physician-reported outcomes, and acute-phase reactant levels. Stepwise logistic regression was used to assess contributors to JA-PASS and JA-CASS. Cutoff values of outcome measures that defined JA-PASS and JA-CASS were determined using both 75th percentile and receiver-operating characteristic (ROC) curve methods. Testing procedures included evaluation of discriminative and construct validity of the satisfaction question and assessment of reliability of JA-PASS and JA-PASS cutoffs.
RESULTS: Of 584 parents, 385 (65.9%) considered their child in JA-PASS. Of 343 children, 236 (68.8%) considered themselves in JA-CASS. Significant contributors to being in either JA-PASS or JA-CASS were absence of active joints, better rating of overall well-being, and better physical function or health. Cutoff values yielded by 75th percentile and ROC curve methods were similar. Parent, child, and physician global ratings yielded the lowest percentage of false-positive misclassification and the best tradeoff between sensitivity and specificity. The satisfaction question showed good discriminative and construct validity and the JA-PASS and JA-PASS cutoffs were found to be stable over time.
CONCLUSION: The acceptable symptom state is a relevant concept for children with JIA and their parents and constitutes a valid outcome measure that is potentially applicable in routine practice and clinical trials.

Entities:  

Mesh:

Year:  2012        PMID: 22298905     DOI: 10.3899/jrheum.110745

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  54 in total

Review 1.  Outcome Scores in Pediatric Rheumatology.

Authors:  Gabriella Giancane; Silvia Rosina; Alessandro Consolaro; Nicolino Ruperto
Journal:  Curr Rheumatol Rep       Date:  2021-03-08       Impact factor: 4.592

Review 2.  Current Research in Outcome Measures for Pediatric Rheumatic and Autoinflammatory Diseases.

Authors:  Erkan Demirkaya; Alessandro Consolaro; Hafize Emine Sonmez; Gabriella Giancane; Dogan Simsek; Angelo Ravelli
Journal:  Curr Rheumatol Rep       Date:  2016-02       Impact factor: 4.592

3.  Seeking insights into the EPidemiology, treatment and Outcome of Childhood Arthritis through a multinational collaborative effort: Introduction of the EPOCA study.

Authors:  Alessandro Consolaro; Nicolino Ruperto; Giovanni Filocamo; Stefano Lanni; Giulia Bracciolini; Marco Garrone; Silvia Scala; Luca Villa; Giuseppe Silvestri; Daniela Tani; Alessandra Zolesi; Alberto Martini; Angelo Ravelli
Journal:  Pediatr Rheumatol Online J       Date:  2012-11-20       Impact factor: 3.054

Review 4.  Update on the management of systemic juvenile idiopathic arthritis and role of IL-1 and IL-6 inhibition.

Authors:  Sriharsha Grevich; Susan Shenoi
Journal:  Adolesc Health Med Ther       Date:  2017-11-09

5.  The Slovak version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Authors:  Veronika Vargová; Tomáš Dallos; Monika Leščišinová; Pavol Mrážik; Alessandro Consolaro; Francesca Bovis; Nicolino Ruperto
Journal:  Rheumatol Int       Date:  2018-04-07       Impact factor: 2.631

6.  The Serbian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Authors:  Gordana Susic; Jelena Vojinovic; Gordana Vijatov-Djuric; Dejan Stevanovic; Dragana Lazarevic; Nada Djurovic; Dusica Novakovic; Alessandro Consolaro; Francesca Bovis; Nicolino Ruperto
Journal:  Rheumatol Int       Date:  2018-04-07       Impact factor: 2.631

7.  The German version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Authors:  Dirk Holzinger; Dirk Foell; Gerd Horneff; Ivan Foeldvari; Nikolay Tzaribachev; Catrin Tzaribachev; Kirsten Minden; Tilmann Kallinich; Gerd Ganser; Lucia Clara; Johannes-Peter Haas; Boris Hügle; Hans-Iko Huppertz; Frank Weller; Alessandro Consolaro; Francesca Bovis; Nicolino Ruperto
Journal:  Rheumatol Int       Date:  2018-04-07       Impact factor: 2.631

8.  The Colombian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Authors:  Clara Malagon; Angela Catalina Mosquera Pongutà; Jaime De Inocencio; Alessandro Consolaro; Francesca Bovis; Nicolino Ruperto
Journal:  Rheumatol Int       Date:  2018-04-07       Impact factor: 2.631

9.  The Ecuadorian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Authors:  Cristina Herrera Mora; Stella Maris Garay; Alessandro Consolaro; Francesca Bovis; Nicolino Ruperto
Journal:  Rheumatol Int       Date:  2018-04-07       Impact factor: 2.631

10.  The American English version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Authors:  Daniel J Lovell; Hermine I Brunner; Sarah Ringold; Pamela F Weiss; Neil Martin; Alessandro Consolaro; Francesca Bovis; Nicolino Ruperto
Journal:  Rheumatol Int       Date:  2018-04-07       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.